Sea Otter Advisors’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300,000
Closed -$90K 207
2023
Q4
$90K Buy
300,000
+150,000
+100% +$46.3K 0.06% 82
2023
Q3
$52.4K Hold
150,000
0.03% 126
2023
Q2
$24K Hold
150,000
0.01% 153
2023
Q1
$21.8K Buy
+150,000
New +$15.2K 0.01% 165

Sea Otter Advisors's DMAQR Position: Q1 2024 in Review

Sea Otter Advisors sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 300,000 shares — an estimated $90K sold.

Sea Otter Advisors first reported a position in DMAQR in Q1 2023 and held it in 4 quarters. The position peaked at $90K in Q4 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • Sea Otter Advisors reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • Sea Otter Advisors sold 300,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $90K.
  • Sea Otter Advisors first reported a position in Deep Medicine Acquisition Corp. Rights in Q1 2023 and held it in 4 quarters.
  • Sea Otter Advisors's Deep Medicine Acquisition Corp. Rights position peaked at $90K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Sea Otter Advisors's 13F filing for Q1 2024, filed 15 May 2024.